Published in Eye (Lond) on January 01, 1987
Retinal vasculitis. Postgrad Med J (1988) 0.93
Retinal vasculitis--a primer. West J Med (1991) 0.81
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
Ischaemic papillopathy. Clinical and fluorescein aniographic review of forty cases. Br J Ophthalmol (1974) 3.56
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain (1995) 2.94
Visual capacity in the hemianopic field following a restricted occipital ablation. Brain (1974) 2.92
Chronic relapsing inflammatory optic neuropathy (CRION). Brain (2003) 2.83
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology (2001) 2.61
Benign retinal vasculitis. Clinical and fluorescein angiographic study. Br J Ophthalmol (1971) 2.32
Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol (1976) 2.20
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15
Tissue-specific antigens. Adv Immunol (1966) 2.15
'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med (1970) 2.13
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Viscosity and retinal vein thrombosis. Br J Ophthalmol (1976) 2.12
Fluorescein fundus photography in the detection of early papilloedema and its differentiation from pseudo-papilloedema. Lancet (1965) 2.12
Hypoxic ocular sequelae of carotid-cavernous fistulae. Study of the caues of visual failure before and after neurosurgical treatment in a series of 25 cases. Br J Ophthalmol (1969) 2.11
The role of the macrophage in delayed hypersensitivity. Br Med Bull (1967) 2.07
The clinical significance of mediators of cellular immunity. Clin Allergy (1971) 2.03
Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens (1999) 2.02
Differential alternative splicing activity of isoforms of polypyrimidine tract binding protein (PTB). RNA (2001) 1.98
A neurovisceral storage disease with vertical supranuclear ophthalmoplegia, and its relationship to Niemann-Pick disease. A report of nine patients. Brain (1973) 1.94
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Factors affecting visual loss in benign intracranial hypertension. Ophthalmology (1984) 1.89
Systemic corticosteroid therapy--side effects and their management. Br J Ophthalmol (1998) 1.81
Ophthalmologic findings in 70 patients with evidence of retinal embolism. Ophthalmology (1982) 1.79
Computer assisted tomography in orbital disease. Br J Ophthalmol (1974) 1.79
Ischaemic papillopathy. Trans Ophthalmol Soc U K (1971) 1.79
Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology (2000) 1.75
Protein factor requirements of the Apaf-1 internal ribosome entry segment: roles of polypyrimidine tract binding protein and upstream of N-ras. Mol Cell Biol (2001) 1.73
Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis. Neurobiol Dis (2001) 1.72
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
Maternal dietary choline availability alters mitosis, apoptosis and the localization of TOAD-64 protein in the developing fetal rat septum. Brain Res Dev Brain Res (1999) 1.65
Fluorescein angiography in the diagnosis of drusen of the disc. Trans Ophthalmol Soc U K (1967) 1.62
In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen. Immunology (1970) 1.60
Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy. Eye (Lond) (1997) 1.58
Questioning questionnaires. Eye (Lond) (2001) 1.58
Fundus changes in histologically confirmed sarcoidosis. Br J Ophthalmol (1981) 1.52
Lymphocyte mitogenic factor in man. Nature (1969) 1.51
Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP. Clin Exp Immunol (1972) 1.51
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Ophthalmoplegia in carotid cavernous sinus fistula. Br J Ophthalmol (1984) 1.43
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.43
Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect (1999) 1.42
Intraocular tuberculosis. Eye (Lond) (1990) 1.42
Retinal vasculitis: a review. J R Soc Med (1979) 1.41
Retinal, choroidal, and optic disc involvement in sarcoidosis. Trans Ophthalmol Soc U K (1976) 1.41
Bilateral sudden visual loss due to sphenoid mucocele in Albright's syndrome. Br J Ophthalmol (1995) 1.40
Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol (1973) 1.39
Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol (1981) 1.39
Radioiodine and Graves' ophthalmopathy reconsidered. Nucl Med Commun (2001) 1.39
The ocular complications of HIV and AIDS. Int J STD AIDS (1997) 1.38
Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol (2000) 1.36
Migraine complicated by ischaemic papillopathy. Lancet (1971) 1.35
"Blindsight": Vision in a field defect. Lancet (1974) 1.32
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol (2003) 1.30
Papilledema and asymptomatic intracranial hypertension in systemic lupus erythematosus. A fluorescein angiographic study of resolving papilledema. Arch Ophthalmol (1968) 1.29
Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol (2000) 1.26
Cytokines in proliferative vitreoretinopathy. Eye (Lond) (1991) 1.26
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys. Exp Parasitol (1970) 1.24
Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families. Brain (1994) 1.22
Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice. J Clin Lab Immunol (1978) 1.20
Neurophysiological investigation in optic nerve disease: combined assessment of the visual evoked response and electroretinogram. Br J Ophthalmol (1978) 1.19
The retinal manifestations of mitochondrial myopathy. A study of 22 cases. Arch Ophthalmol (1985) 1.18
Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy. Br J Ophthalmol (2005) 1.18
Scleral canal size and optic nerve head drusen. Am J Ophthalmol (1985) 1.17
Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii. Clin Exp Immunol (1974) 1.17
Maternal choline availability alters the localization of p15Ink4B and p27Kip1 cyclin-dependent kinase inhibitors in the developing fetal rat brain hippocampus. Dev Neurosci (2001) 1.15
Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology (1988) 1.15
TRIP: a novel double stranded RNA binding protein which interacts with the leucine rich repeat of flightless I. Nucleic Acids Res (1998) 1.14
Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol (1973) 1.14
Late onset Leber's optic neuropathy: a case confused with ischaemic optic neuropathy. Br J Ophthalmol (1992) 1.14
Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology (1995) 1.13
Differential diagnosis of unilateral optic disc oedema. Trans Ophthalmol Soc U K (1980) 1.13
Papilloedema, a complication of progressive diaphyseal dysplasia: a series of three case reports. Br J Ophthalmol (1998) 1.12
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Visual loss and falls: a review. Eye (Lond) (2010) 1.11
Immunoflorescence studies of Leishmania enriettii infection in the guinea pig. Trans R Soc Trop Med Hyg (1974) 1.11
IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol (1996) 1.11
Peripheral leucocyte migration. Inhibited by diphtheroid organisms isolated from patients with rheumatoid arthritis. Ann Rheum Dis (1970) 1.10
HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens (1999) 1.10
Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ (1995) 1.09
The production of lymphocyte mitogenic factor and migration-inhibition factor by antigen-stimulated lymphocytes of subjects with grass pollen allergy. Clin Exp Immunol (1971) 1.09
Surgical treatment of superior bullous rhegmatogenous retinal detachments. Br J Ophthalmol (1985) 1.08